Global Short Bowel Syndrome (SBS) Drugs Market Research Report 2020

Global Short Bowel Syndrome (SBS) Drugs Market Research Report 2020

Table of Contents
1 Short Bowel Syndrome (SBS) Drugs Market Overview
1.1 Product Overview and Scope of Short Bowel Syndrome (SBS) Drugs
1.2 Short Bowel Syndrome (SBS) Drugs Segment by Type
1.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Glucagon-Like Peptide-2 (GLP-2)
1.2.3 Growth Hormone
1.2.4 Glutamine
1.2.5 Other
1.3 Short Bowel Syndrome (SBS) Drugs Segment by Application
1.3.1 Short Bowel Syndrome (SBS) Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Global Short Bowel Syndrome (SBS) Drugs Market Size Estimates and Forecasts
1.4.1 Global Short Bowel Syndrome (SBS) Drugs Revenue 2015-2026
1.4.2 Global Short Bowel Syndrome (SBS) Drugs Sales 2015-2026
1.4.3 Short Bowel Syndrome (SBS) Drugs Market Size by Region: 2020 Versus 2026
2 Global Short Bowel Syndrome (SBS) Drugs Market Competition by Manufacturers
2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Short Bowel Syndrome (SBS) Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Short Bowel Syndrome (SBS) Drugs Manufacturing Sites, Area Served, Product Type
2.5 Short Bowel Syndrome (SBS) Drugs Market Competitive Situation and Trends
2.5.1 Short Bowel Syndrome (SBS) Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Short Bowel Syndrome (SBS) Drugs Players (Opinion Leaders)
3 Short Bowel Syndrome (SBS) Drugs Retrospective Market Scenario by Region
3.1 Global Short Bowel Syndrome (SBS) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Short Bowel Syndrome (SBS) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.3.1 North America Short Bowel Syndrome (SBS) Drugs Sales by Country
3.3.2 North America Short Bowel Syndrome (SBS) Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.4.1 Europe Short Bowel Syndrome (SBS) Drugs Sales by Country
3.4.2 Europe Short Bowel Syndrome (SBS) Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region
3.5.2 Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.6.1 Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country
3.6.2 Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country
3.7.2 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Short Bowel Syndrome (SBS) Drugs Historic Market Analysis by Type
4.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2015-2020)
4.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Short Bowel Syndrome (SBS) Drugs Price Market Share by Type (2015-2020)
4.4 Global Short Bowel Syndrome (SBS) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Short Bowel Syndrome (SBS) Drugs Historic Market Analysis by Application
5.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application (2015-2020)
5.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Short Bowel Syndrome (SBS) Drugs Price by Application (2015-2020)
6 Company Profiles and Key Figures in Short Bowel Syndrome (SBS) Drugs Business
6.1 Merck
6.1.1 Corporation Information
6.1.2 Merck Description, Business Overview and Total Revenue
6.1.3 Merck Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Merck Products Offered
6.1.5 Merck Recent Development
6.2 Takeda
6.2.1 Takeda Short Bowel Syndrome (SBS) Drugs Production Sites and Area Served
6.2.2 Takeda Description, Business Overview and Total Revenue
6.2.3 Takeda Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Takeda Products Offered
6.2.5 Takeda Recent Development
6.3 Emmaus Medical
6.3.1 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Production Sites and Area Served
6.3.2 Emmaus Medical Description, Business Overview and Total Revenue
6.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Emmaus Medical Products Offered
6.3.5 Emmaus Medical Recent Development
6.4 Ardelyx
6.4.1 Ardelyx Short Bowel Syndrome (SBS) Drugs Production Sites and Area Served
6.4.2 Ardelyx Description, Business Overview and Total Revenue
6.4.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Ardelyx Products Offered
6.4.5 Ardelyx Recent Development
6.5 Naia Pharmaceuticals
6.5.1 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Production Sites and Area Served
6.5.2 Naia Pharmaceuticals Description, Business Overview and Total Revenue
6.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Naia Pharmaceuticals Products Offered
6.5.5 Naia Pharmaceuticals Recent Development
6.6 Nutrinia
6.6.1 Nutrinia Short Bowel Syndrome (SBS) Drugs Production Sites and Area Served
6.6.2 Nutrinia Description, Business Overview and Total Revenue
6.6.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Nutrinia Products Offered
6.6.5 Nutrinia Recent Development
6.7 OxThera
6.6.1 OxThera Short Bowel Syndrome (SBS) Drugs Production Sites and Area Served
6.6.2 OxThera Description, Business Overview and Total Revenue
6.6.3 OxThera Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 OxThera Products Offered
6.7.5 OxThera Recent Development
6.8 Sancilio Pharmaceuticals
6.8.1 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Production Sites and Area Served
6.8.2 Sancilio Pharmaceuticals Description, Business Overview and Total Revenue
6.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Sancilio Pharmaceuticals Products Offered
6.8.5 Sancilio Pharmaceuticals Recent Development
6.9 Zealand Pharma
6.9.1 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Production Sites and Area Served
6.9.2 Zealand Pharma Description, Business Overview and Total Revenue
6.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Zealand Pharma Products Offered
6.9.5 Zealand Pharma Recent Development
7 Short Bowel Syndrome (SBS) Drugs Manufacturing Cost Analysis
7.1 Short Bowel Syndrome (SBS) Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Short Bowel Syndrome (SBS) Drugs
7.4 Short Bowel Syndrome (SBS) Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Short Bowel Syndrome (SBS) Drugs Distributors List
8.3 Short Bowel Syndrome (SBS) Drugs Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Short Bowel Syndrome (SBS) Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Short Bowel Syndrome (SBS) Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Short Bowel Syndrome (SBS) Drugs by Type (2021-2026)
10.2 Short Bowel Syndrome (SBS) Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Short Bowel Syndrome (SBS) Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Short Bowel Syndrome (SBS) Drugs by Application (2021-2026)
10.3 Short Bowel Syndrome (SBS) Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Short Bowel Syndrome (SBS) Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Short Bowel Syndrome (SBS) Drugs by Region (2021-2026)
10.4 North America Short Bowel Syndrome (SBS) Drugs Estimates and Projections (2021-2026)
10.5 Europe Short Bowel Syndrome (SBS) Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Short Bowel Syndrome (SBS) Drugs Estimates and Projections (2021-2026)
10.7 Latin America Short Bowel Syndrome (SBS) Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) Comparison by Application: 2020 VS 2026
Table 3. Global Short Bowel Syndrome (SBS) Drugs Market Size by Type (K Pcs) (US$ Million) (2020 VS 2026)
Table 4. Global Key Short Bowel Syndrome (SBS) Drugs Manufacturers Covered in This Study
Table 5. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Manufacturers (2015-2020)
Table 6. Global Short Bowel Syndrome (SBS) Drugs Sales Share by Manufacturers (2015-2020)
Table 7. Global Short Bowel Syndrome (SBS) Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Short Bowel Syndrome (SBS) Drugs Average Price (USD/Pcs) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Short Bowel Syndrome (SBS) Drugs Sales Sites and Area Served
Table 11. Manufacturers Short Bowel Syndrome (SBS) Drugs Product Types
Table 12. Global Short Bowel Syndrome (SBS) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Short Bowel Syndrome (SBS) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome (SBS) Drugs as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Short Bowel Syndrome (SBS) Drugs Players
Table 16. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Region (2015-2020)
Table 17. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2015-2020)
Table 18. Global Short Bowel Syndrome (SBS) Drugs Revenue (Million US$) by Region (2015-2020)
Table 19. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2015-2020)
Table 20. North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2015-2020) (K Pcs)
Table 21. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2015-2020)
Table 22. North America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2015-2020)
Table 24. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2015-2020) (K Pcs)
Table 25. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2015-2020)
Table 26. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region (2015-2020) (K Pcs)
Table 29. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2015-2020)
Table 32. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country (2015-2020) (K Pcs)
Table 33. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2015-2020)
Table 34. Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2015-2020) (K Pcs)
Table 37. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2015-2020)
Table 40. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Type (2015-2020)
Table 41. Global Short Bowel Syndrome (SBS) Drugs Sales Share by Type (2015-2020)
Table 42. Global Short Bowel Syndrome (SBS) Drugs Revenue (Million US$) by Type (2015-2020)
Table 43. Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Type (2015-2020)
Table 44. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Type (2015-2020)
Table 45. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Application (2015-2020)
Table 46. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application (2015-2020)
Table 47. Global Short Bowel Syndrome (SBS) Drugs Sales Growth Rate by Application (2015-2020)
Table 48. Merck Short Bowel Syndrome (SBS) Drugs Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 51. Merck Main Product
Table 52. Merck Recent Development
Table 53. Takeda Short Bowel Syndrome (SBS) Drugs Corporation Information
Table 54. Takeda Corporation Information
Table 55. Takeda Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 56. Takeda Main Product
Table 57. Takeda Recent Development
Table 58. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Corporation Information
Table 59. Emmaus Medical Corporation Information
Table 60. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 61. Emmaus Medical Main Product
Table 62. Emmaus Medical Recent Development
Table 63. Ardelyx Short Bowel Syndrome (SBS) Drugs Corporation Information
Table 64. Ardelyx Corporation Information
Table 65. Ardelyx Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 66. Ardelyx Main Product
Table 67. Ardelyx Recent Development
Table 68. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Corporation Information
Table 69. Naia Pharmaceuticals Corporation Information
Table 70. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 71. Naia Pharmaceuticals Main Product
Table 72. Naia Pharmaceuticals Recent Development
Table 73. Nutrinia Short Bowel Syndrome (SBS) Drugs Corporation Information
Table 74. Nutrinia Corporation Information
Table 75. Nutrinia Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Nutrinia Main Product
Table 77. Nutrinia Recent Development
Table 78. OxThera Short Bowel Syndrome (SBS) Drugs Corporation Information
Table 79. OxThera Corporation Information
Table 80. OxThera Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. OxThera Main Product
Table 82. OxThera Recent Development
Table 83. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Corporation Information
Table 84. Sancilio Pharmaceuticals Corporation Information
Table 85. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Sancilio Pharmaceuticals Main Product
Table 87. Sancilio Pharmaceuticals Recent Development
Table 88. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Corporation Information
Table 89. Zealand Pharma Corporation Information
Table 90. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Zealand Pharma Main Product
Table 92. Zealand Pharma Recent Development
Table 93. Sales Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Short Bowel Syndrome (SBS) Drugs Distributors List
Table 96. Short Bowel Syndrome (SBS) Drugs Customers List
Table 97. Market Key Trends
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) Forecast by Type (2021-2026)
Table 101. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share Forecast by Type (2021-2026)
Table 102. Global Short Bowel Syndrome (SBS) Drugs Revenue (Million US$) Forecast by Type (2021-2026)
Table 103. Global Short Bowel Syndrome (SBS) Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 104. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) Forecast by Application (2021-2026)
Table 105. Global Short Bowel Syndrome (SBS) Drugs Revenue (Million US$) Forecast by Application (2021-2026)
Table 106. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) Forecast by Region (2021-2026)
Table 107. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share Forecast by Region (2021-2026)
Table 108. Global Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Short Bowel Syndrome (SBS) Drugs
Figure 2. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type: 2020 VS 2026
Figure 3. Glucagon-Like Peptide-2 (GLP-2) Product Picture
Figure 4. Growth Hormone Product Picture
Figure 5. Glutamine Product Picture
Figure 6. Other Product Picture
Figure 7. Global Short Bowel Syndrome (SBS) Drugs Consumption Market Share by Application: 2020 VS 2026
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Retail Pharmacies
Figure 11. Global Short Bowel Syndrome (SBS) Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Short Bowel Syndrome (SBS) Drugs Sales Capacity (K Pcs) (2015-2026)
Figure 13. Global Short Bowel Syndrome (SBS) Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Short Bowel Syndrome (SBS) Drugs Sales Share by Manufacturers in 2020
Figure 15. Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Short Bowel Syndrome (SBS) Drugs Revenue in 2019
Figure 17. Short Bowel Syndrome (SBS) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2015-2020)
Figure 19. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region in 2019
Figure 20. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2015-2020)
Figure 21. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region in 2019
Figure 22. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country in 2019
Figure 23. North America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country in 2019
Figure 24. U.S. Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 25. U.S. Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 27. Canada Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country in 2019
Figure 29. Europe Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country in 2019
Figure 30. Germany Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 31. Germany Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 33. France Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. U.K. Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. Italy Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Russia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region in 2019
Figure 41. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region in 2019
Figure 42. China Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 43. China Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. Japan Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. South Korea Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. India Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Australia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Taiwan Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Indonesia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Thailand Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. Malaysia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Philippines Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Vietnam Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country in 2019
Figure 65. Latin America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country in 2019
Figure 66. Mexico Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Mexico Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Brazil Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Argentina Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country in 2019
Figure 74. Turkey Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Turkey Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Saudi Arabia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Short Bowel Syndrome (SBS) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. U.A.E Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Short Bowel Syndrome (SBS) Drugs by Type (2015-2020)
Figure 81. Sales Market Share of Short Bowel Syndrome (SBS) Drugs by Type in 2019
Figure 82. Revenue Share of Short Bowel Syndrome (SBS) Drugs by Type (2015-2020)
Figure 83. Revenue Market Share of Short Bowel Syndrome (SBS) Drugs by Type in 2019
Figure 84. Global Short Bowel Syndrome (SBS) Drugs Sales Growth by Type (2015-2020) (K Pcs)
Figure 85. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application (2015-2020)
Figure 86. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Short Bowel Syndrome (SBS) Drugs by Application (2015-2020)
Figure 88. Global Revenue Share of Short Bowel Syndrome (SBS) Drugs by Application in 2020
Figure 89. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Emmaus Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Ardelyx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Naia Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Nutrinia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. OxThera Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Sancilio Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Zealand Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of Short Bowel Syndrome (SBS) Drugs
Figure 100. Manufacturing Process Analysis of Short Bowel Syndrome (SBS) Drugs
Figure 101. Short Bowel Syndrome (SBS) Drugs Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 106. North America Short Bowel Syndrome (SBS) Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Short Bowel Syndrome (SBS) Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Short Bowel Syndrome (SBS) Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs